| Project/Area Number |
13660302
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Basic veterinary science/Basic zootechnical science
|
|---|
| Research Institution | Kagoshima University |
|---|
Principal Investigator |
MIYAMOTO Atsushi Kagoshima University, Faculty of Agriculture, Associate professor, 農学部, 助教授 (70219806)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NISHIO Akira Kagoshima University, Faculty of Agriculture, Professor, 農学部, 教授 (90133181)
|
|---|
| Project Period (FY) |
2001 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2002: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2001: ¥1,900,000 (Direct Cost: ¥1,900,000)
|
|---|
| Keywords | Bradykinin / Basilar artery / Vasoreactivity / Tyrosine phosphorylation / cultured endothelial cell / NO production / Losartan / HOE140 / G-蛋白質 / チロシンキナーゼ阻害薬 / チロシンフォスファターゼ阻害薬 / 冠状動脈 / ブタ / ウシ |
|---|
| Research Abstract |
(1)Nitric oxide (NO) is spontaneously released from cultured porcine basilar arterial endothelial cells under no stimulation conditions. Bradykinin (BK) enhanced the NO production in a concentration-dependent manner. The enhanced NO production was inhibited by treatments of a selective B_2 receptor antagonist, HOE140, or a NO synthase inhibitor, L-nitro-arginine.
(2)Angiotensin (Ang) II induced a contraction in isolated porcine basilar arterial ring. A selective B_2 antagonist, HOE140, inhibited the AngII-induced contraction, while an Ang converting enzyme (ACE) inhibitor, captopril, enhanced the Ang II-induced contraction.
(3)BK induces endothelium-dependent relaxation following by contraction in isolated porcine basilar arterial ring. In the presence of L-nitro-arginine (10^<-4> M), BK induced contraction but not relaxation. The BK-induced contraction was not inhibited by a selective AT_1 receptor antagonist, losartan.
These results suggest that there might be some interaction between bradykinin and Ang receptors. Further experiments appears to be needed in this point.
|
